N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide

C29H34N4O3 — CID 10163227

IUPACN-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide
SMILESCc1ccc2nc(-c3cn[nH]c3-c3cccc(NC(=O)COC4CC(C)CCC4C(C)C)c3)oc2c1
InChIInChI=1S/C29H34N4O3/c1-17(2)22-10-8-18(3)12-25(22)35-16-27(34)31-21-7-5-6-20(14-21)28-23(15-30-33-28)29-32-24-11-9-19(4)13-26(24)36-29/h5-7,9,11,13-15,17-18,22,25H,8,10,12,16H2,1-4H3,(H,30,33)(H,31,34)
InChIKeyCBCKQJDBNZQCGC-UHFFFAOYSA-N
MW486.62 g/mol
LogP6.61
Rot. Bonds7

About N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide

N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide (PubChem CID 10163227) has the molecular formula C29H34N4O3 and a molecular weight of 486.62 g/mol. Its IUPAC name is N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide.

Molecular Properties

Compound NameN-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide
PubChem CID10163227
Molecular FormulaC29H34N4O3
Molecular Weight486.62 g/mol
Exact Mass486.26
IUPAC NameN-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide
SMILESCc1ccc2nc(-c3cn[nH]c3-c3cccc(NC(=O)COC4CC(C)CCC4C(C)C)c3)oc2c1
InChIInChI=1S/C29H34N4O3/c1-17(2)22-10-8-18(3)12-25(22)35-16-27(34)31-21-7-5-6-20(14-21)28-23(15-30-33-28)29-32-24-11-9-19(4)13-26(24)36-29/h5-7,9,11,13-15,17-18,22,25H,8,10,12,16H2,1-4H3,(H,30,33)(H,31,34)
InChIKeyCBCKQJDBNZQCGC-UHFFFAOYSA-N
XLogP6.61
TPSA93.04 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms36
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500486.62
LogP ≤ 56.61
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide?
The IUPAC name of N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide (CID 10163227) is N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide.
What is the SMILES notation for N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide?
The canonical SMILES for N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide is Cc1ccc2nc(-c3cn[nH]c3-c3cccc(NC(=O)COC4CC(C)CCC4C(C)C)c3)oc2c1.
What is the InChIKey of N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide?
The InChIKey is CBCKQJDBNZQCGC-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H34N4O3/c1-17(2)22-10-8-18(3)12-25(22)35-16-27(34)31-21-7-5-6-20(14-21)28-23(15-30-33-28)29-32-24-11-9-19(4)13-26(24)36-29/h5-7,9,11,13-15,17-18,22,25H,8,10,12,16H2,1-4H3,(H,30,33)(H,31,34).
What are the key properties of N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide?
N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide has a molecular weight of 486.62 g/mol, XLogP of 6.61, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[4-(6-methyl-1,3-benzoxazol-2-yl)-1H-pyrazol-5-yl]phenyl]-2-(5-methyl-2-propan-2-ylcyclohexyl)oxyacetamide is sourced from PubChem (CID 10163227), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).